MimeTech Srl was incorporated in December of 2004 by two scientists, Antonio Guarna, Professor of Organic Chemistry, and Federico Cozzolino, Professor of Clinical Laboratory Sciences, both at the University of Firenze, to further develop pharmaceutical applications of a novel library of synthetic neurotrophin mimetics.
At the hub of our technology platform is a cutting-edge series of synthetic neurotrophin mimetics. The flaghship compound, whose name is Udonitrectag, is endowed with potent NGF (Nerve Growth Factor) as well as BDNF (Brain-Derived Neurotrophic Factor) mimetic activity. Neurotrophins are proteins essential for the proper control of cell survival; dysregulation of their functions is linked to onset and/or persistence of very important and largely diffuse clinical conditions, the so-called degenerative diseases: Alzheimer Disease, Parkinson Disease, Acute Myocardial Infarction, Stroke, Glaucoma are relevant examples of degenerative disorders.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Via Della Cernaia, Florence,tuscany 50129,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://mimetech.eu/
- Keywords
- Neurotrophin mimetics, Rare diseases, Diabetic Foot Ulcer (DFU), Solid organ transplant, Ophthalmic diseases, Dermatologic diseases.
- HQ
- Florence, Tuscany
Mimetech Srl Questions
Mimetech Srl's website is https://mimetech.eu/
Mimetech Srl's LinkedIn profile is https://it.linkedin.com/company/mimetech-srl
Mimetech Srl has
6 employees.
View email and phone details for 6
employees at Mimetech Srl.
Mimetech Srl's industry is
Biotechnology Research
Mimetech Srl's top competitors are
Vismederi Group,
Genetic Innovation S.r.l.,
Biomolecular Diagnostic Srl,
Biochemie Lab S.r.l.,
Biomérieux,
Dival Toscana Srl,
Genando,
Raintree Partners Capital,
Toscomedical,
Fheritale.
Mimetech Srl's categories are Biotechnology Research
Mimetech Srl's founding year is 2004
